Published in Int J Parasitol on November 01, 2000
Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev (2012) 4.07
Toxoplasmosis: A history of clinical observations. Int J Parasitol (2009) 3.39
Toxoplasma gondii infection in humans in China. Parasit Vectors (2011) 2.74
Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis (2003) 2.73
Toxoplasma gondii and schizophrenia. Emerg Infect Dis (2003) 1.76
Seroprevalence of Toxoplasma gondii infection in pet dogs in Lanzhou, Northwest China. Parasit Vectors (2011) 1.71
Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One (2014) 1.57
Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health (2005) 1.57
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity. J Med Chem (2012) 1.56
Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine. Infect Immun (2007) 1.55
Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis (2005) 1.51
Effects of toxoplasma on human behavior. Schizophr Bull (2007) 1.51
Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol (2005) 1.43
Toxoplasma gondii Infection in Pregnant Women: A Seroprevalence and Case-Control Study in Eastern China. Biomed Res Int (2015) 1.40
Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infect Dis (2009) 1.37
Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis (2010) 1.37
Chromerid genomes reveal the evolutionary path from photosynthetic algae to obligate intracellular parasites. Elife (2015) 1.36
Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence. APMIS (2009) 1.36
Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev (2011) 1.35
The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr Bull (2007) 1.31
In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin. Antimicrob Agents Chemother (2006) 1.31
A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr Bull (2007) 1.30
Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol (2011) 1.28
TgCDPK3 regulates calcium-dependent egress of Toxoplasma gondii from host cells. PLoS Pathog (2012) 1.27
Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. PLoS One (2012) 1.27
Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. BMC Infect Dis (2013) 1.25
Loop-mediated isothermal amplification (LAMP): early detection of Toxoplasma gondii infection in mice. Parasit Vectors (2012) 1.25
Can the common brain parasite, Toxoplasma gondii, influence human culture? Proc Biol Sci (2006) 1.23
Discovery of parasite virulence genes reveals a unique regulator of chromosome condensation 1 ortholog critical for efficient nuclear trafficking. Proc Natl Acad Sci U S A (2007) 1.21
Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development. PLoS Pathog (2006) 1.19
Modulation of the host cell proteome by the intracellular apicomplexan parasite Toxoplasma gondii. Infect Immun (2007) 1.18
First report of Toxoplasma gondii seroprevalence in peafowls in Yunnan Province, Southwestern China. Parasit Vectors (2012) 1.17
Seroprevalence of Toxoplasma gondii in horses and donkeys in Yunnan Province, Southwestern China. Parasit Vectors (2013) 1.17
Autophagy is a cell death mechanism in Toxoplasma gondii. Cell Microbiol (2012) 1.16
Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia. Parasit Vectors (2013) 1.16
Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res (2006) 1.16
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. J Immunol (2012) 1.16
Proteomic analysis of fractionated Toxoplasma oocysts reveals clues to their environmental resistance. PLoS One (2012) 1.15
Infection with Toxoplasma gondii results in dysregulation of the host cell cycle. Cell Microbiol (2008) 1.14
Targeting purine and pyrimidine metabolism in human apicomplexan parasites. Curr Drug Targets (2007) 1.14
Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol Res (2010) 1.12
Quantitative in vivo analyses reveal calcium-dependent phosphorylation sites and identifies a novel component of the Toxoplasma invasion motor complex. PLoS Pathog (2011) 1.12
Toxoplasma: the next 100years. Microbes Infect (2008) 1.12
Toxoplasma seroprevalence in a rural population in France: detection of a household effect. BMC Infect Dis (2009) 1.11
Toxoplasmosis. Handb Clin Neurol (2013) 1.11
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl Trop Dis (2008) 1.10
Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol Res (2008) 1.10
Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Parasit Vectors (2012) 1.09
Acquired infection with Toxoplasma gondii in adult mice results in sensorimotor deficits but normal cognitive behavior despite widespread brain pathology. Microbes Infect (2010) 1.09
Structural characterization of apical membrane antigen 1 (AMA1) from Toxoplasma gondii. J Biol Chem (2010) 1.08
Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? J Exp Biol (2013) 1.08
A Toxoplasma palmitoyl acyl transferase and the palmitoylated armadillo repeat protein TgARO govern apical rhoptry tethering and reveal a critical role for the rhoptries in host cell invasion but not egress. PLoS Pathog (2013) 1.08
Changing climate-changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res (2009) 1.07
The Toxoplasma gondii cyst wall protein CST1 is critical for cyst wall integrity and promotes bradyzoite persistence. PLoS Pathog (2013) 1.06
The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS One (2011) 1.06
Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors (2015) 1.06
Human innate immunity to Toxoplasma gondii is mediated by host caspase-1 and ASC and parasite GRA15. MBio (2013) 1.05
Mice infected with low-virulence strains of Toxoplasma gondii lose their innate aversion to cat urine, even after extensive parasite clearance. PLoS One (2013) 1.05
Maintained seroprevalence of toxoplasmosis among the residents of Jeju island, Korea. Korean J Parasitol (2011) 1.04
The spatial ecology of free-ranging domestic pigs (Sus scrofa) in western Kenya. BMC Vet Res (2013) 1.04
Rapid immunochromatographic test using recombinant SAG2 for detection of antibodies against Toxoplasma gondii in cats. J Clin Microbiol (2004) 1.04
Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil. Appl Environ Microbiol (2012) 1.04
Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis (2011) 1.03
Occupational health and safety in small animal veterinary practice: Part II--Parasitic zoonotic diseases. Can Vet J (2002) 1.03
Methods to produce and safely work with large numbers of Toxoplasma gondii oocysts and bradyzoite cysts. J Microbiol Methods (2011) 1.03
The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun (2003) 1.02
Toxoplasma H2A variants reveal novel insights into nucleosome composition and functions for this histone family. J Mol Biol (2009) 1.02
Prevalence and risk factors of toxoplasmosis among pregnant women in Fortaleza, Northeastern Brazil. Am J Trop Med Hyg (2010) 1.02
DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery. Proc Biol Sci (2010) 1.02
Retracted Reactive oxygen species-triggered trophoblast apoptosis is initiated by endoplasmic reticulum stress via activation of caspase-12, CHOP, and the JNK pathway in Toxoplasma gondii infection in mice. Infect Immun (2012) 1.01
Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo. MBio (2015) 1.01
Neglected tropical diseases as hidden causes of cardiovascular disease. PLoS Negl Trop Dis (2012) 1.01
Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice. BMC Biotechnol (2010) 1.01
Targeting of the central nervous system by Listeria monocytogenes. Virulence (2012) 1.01
The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites. Parasitology (2014) 1.01
Investigation of Neospora caninum, Hammondia sp., and Toxoplasma gondii in tissues from slaughtered beef cattle in Bahia, Brazil. Parasitol Res (2009) 1.01
Genetic characterization of Toxoplasma gondii revealed highly diverse genotypes for isolates from newborns with congenital toxoplasmosis in southeastern Brazil. J Clin Microbiol (2013) 1.01
Evaluation of a recombinant multiepitope peptide for serodiagnosis of Toxoplasma gondii infection. Clin Vaccine Immunol (2012) 1.00
A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population. Parasit Vectors (2012) 1.00
Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar. Parasit Vectors (2008) 1.00
The parasite fauna of stray domestic cats (Felis catus) in Dubai, United Arab Emirates. Parasitol Res (2009) 1.00
Toxoplasma gondii: host-parasite interaction and behavior manipulation. Parasitol Res (2009) 0.99
Structural and functional characterization of SporoSAG: a SAG2-related surface antigen from Toxoplasma gondii. J Biol Chem (2010) 0.99
Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun (2003) 0.99
Serological survey of Toxoplasma gondii in Tibetan mastiffs (Canis lupus familiaris) and yaks (Bos grunniens) in Qinghai, China. Parasit Vectors (2012) 0.99
Babesia divergens and Neospora caninum apical membrane antigen 1 structures reveal selectivity and plasticity in apicomplexan parasite host cell invasion. Protein Sci (2013) 0.98
Processing and secretion of ROP13: A unique Toxoplasma effector protein. Int J Parasitol (2010) 0.98
Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies. Clin Vaccine Immunol (2013) 0.98
Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev (2013) 0.98
Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat Rev Microbiol (2013) 0.98
Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar. Am J Trop Med Hyg (2010) 0.97
Serological prevalence of Toxoplasma gondii antibodies in pregnant women from Southern Brazil. Parasitol Res (2010) 0.97
Age-related Toxoplasma gondii seroprevalence in Dutch wild boar inconsistent with lifelong persistence of antibodies. PLoS One (2011) 0.97
Latent toxoplasmosis and human. Iran J Parasitol (2012) 0.97
Biological role of surface Toxoplasma gondii antigen in development of vaccine. World J Gastroenterol (2006) 0.96
Toxoplasma gondii, source to sea: higher contribution of domestic felids to terrestrial parasite loading despite lower infection prevalence. Ecohealth (2013) 0.96
Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAs. Infect Agent Cancer (2013) 0.96
Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis. PLoS Negl Trop Dis (2013) 0.96
Waterborne toxoplasmosis, northeastern Brazil. Emerg Infect Dis (2007) 0.96
Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science (1948) 19.46
Toxoplasmic encephalitis in AIDS. Clin Infect Dis (1992) 7.64
Toxoplasmic encephalomyelitis: III. A new case of granulomatous encephalomyelitis due to a protozoon. Am J Pathol (1939) 7.25
Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis (1995) 6.79
Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet (1997) 4.36
Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med (1994) 4.32
Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev (1998) 3.59
Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA (1984) 3.48
Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med (1988) 3.15
Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med (1994) 2.94
Coccidian-like nature of Toxoplasma gondii. Br Med J (1970) 2.67
Experimental transmission of Toxoplasma gondii. Nature (1965) 2.66
Present status of clinical manifestations of toxoplasmosis in man; indications and provisions for routine serologic diagnosis. J Am Med Assoc (1952) 2.62
Ocular toxoplasmosis. Br J Ophthalmol (1973) 2.60
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis (1994) 2.58
Epidemic toxoplasmosis associated with infected cats. N Engl J Med (1979) 2.55
Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet (1999) 2.54
Foodborne outbreaks of human toxoplasmosis. J Infect Dis (1997) 2.53
Toxoplasmosis needs evaluation. An overview and proposals. Am J Dis Child (1989) 2.49
Prenatal diagnosis of congenital toxoplasmosis. Lancet (1985) 2.43
An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol (1992) 2.41
Ocular toxoplasmosis. An old disease revisited. JAMA (1994) 2.41
Advances in the life cycle of Toxoplasma gondii. Int J Parasitol (1998) 2.34
Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science (1970) 2.19
[Epidemiological study on toxoplasmosis: the influence of cooking slaughter-animal meat on the incidence of human infection]. Rev Fr Etud Clin Biol (1965) 2.09
Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N Engl J Med (1982) 2.07
Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis (1996) 2.04
Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol (1996) 2.04
Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis (1999) 2.01
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 1.89
Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects. Hum Pathol (1975) 1.86
Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute. Cancer (1968) 1.80
Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet (1983) 1.80
Toxoplasma chorioretinitis in adults. AMA Arch Ophthalmol (1952) 1.75
Toxoplasmosis. J Am Vet Med Assoc (1994) 1.66
The resistance of the encysted form of Toxoplasma gondii. J Parasitol (1960) 1.63
Longitudinal study of Toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect (1992) 1.60
Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med (1995) 1.58
Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis (1995) 1.56
Entamoeba, giardia and toxoplasma: clones or cryptic species? Parasitol Today (1993) 1.52
Potential contamination of drinking water with Toxoplasma gondii oocysts. Epidemiol Infect (1999) 1.52
Systematic serologic screening for toxoplasmosis in pregnancy. Obstet Gynecol (1993) 1.50
Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology (1998) 1.50
Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis. Am J Epidemiol (1993) 1.50
Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii. J Clin Pathol (1989) 1.49
Toxoplasma gondii oocyst survival under defined temperatures. J Parasitol (1998) 1.48
Life cycle of toxoplasma gondii. Br Med J (1969) 1.48
Western blot analysis of stray cat sera against Toxoplasma gondii and the diagnostic availability of monoclonal antibodies in sandwich-ELISA. Korean J Parasitol (1999) 1.47
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. Ann Intern Med (1995) 1.47
A glandular form of toxoplasmosis in connection with pregnancy. Acta Med Scand (1951) 1.46
[The serum markers in the pregnant population of the basic health area of El Natahoyo (Gijón)]. Aten Primaria (1996) 1.46
Toxoplasmosis infection associated with raw goat's milk. JAMA (1982) 1.44
Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. J Parasitol (1995) 1.43
Infectivity of low numbers of Toxoplasma gondii oocysts to pigs. J Parasitol (1996) 1.43
Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet (1991) 1.41
Whatever became of Isospora bigemina? Parasitol Today (1987) 1.41
The Toxoplasma gondii oocyst from cat feces. J Exp Med (1970) 1.38
[Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy]. Ann Pediatr (Paris) (1984) 1.36
Ocular involvement in toxoplasmosis. Br J Ophthalmol (1993) 1.34
Toxoplasma gondii in Iowa sows: comparison of antibody titers to isolation of T. gondii by bioassays in mice and cats. J Parasitol (1995) 1.30
Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol (1988) 1.29
Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl (1992) 1.28
Outbreak of toxoplasmosis in a family and documentation of acquired retinochoroiditis. Am J Med (1978) 1.27
The prevalence of anti-Toxoplasma gondii antibodies in Ghanaian sheep and goats. Acta Trop (2000) 1.25
Toxoplasma gondii: the oocyst, sporozoite, and infection of cultured cells. Science (1970) 1.23
Simultaneous diagnosis of toxoplasmosis in goats and goatowner's family. Scand J Infect Dis (1990) 1.23
Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J Antimicrob Chemother (1988) 1.23
Detection of Toxoplasma gondii oocysts in drinking water. Appl Environ Microbiol (1998) 1.23
Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol (1994) 1.22
Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia. Eur J Epidemiol (1998) 1.21
An outbreak of toxoplasmosis in pregnant women in northern Québec. J Infect Dis (1990) 1.20
Western blot analysis of the antibody response of patients with AIDS and toxoplasma encephalitis: antigenic diversity among Toxoplasma strains. J Infect Dis (1988) 1.20
Performance of European laboratories testing serum samples for Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (1996) 1.20
[Congenital toxoplasmosis. 5 cases of mother-to-child transmission of pre-pregnancy infection]. Presse Med (1990) 1.17
Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the U.K. J Infect (1998) 1.16
Infectivity of Toxoplasma gondii in mutton following curing, smoking, freezing or microwave cooking. Int J Food Microbiol (1992) 1.16
[Acquired toxoplasmosis of ocular or neurologic site: 49 cases]. Presse Med (1996) 1.16
Prevalence of antibodies to Neospora caninum and Toxoplasma gondii in cattle and water buffaloes in southern Vietnam. Vet Parasitol (1998) 1.15
Transmission of Toxoplasma gondii in Panama City, Panama: a five-year prospective cohort study of children, cats, rodents, birds, and soil. Am J Trop Med Hyg (1995) 1.14
Risk factors for recent toxoplasma infection in pregnant women in Naples. Epidemiol Infect (1996) 1.14
Toxoplasmosis: effectiveness of enzyme immunoassay screening. Med Lab Sci (1989) 1.14
Toxoplasma antibody titers by ELISA and indirect latex agglutination test in pregnant women. Korean J Parasitol (1996) 1.14
The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study. Scand J Infect Dis Suppl (1992) 1.13
An outbreak of toxoplasmosis linked to cats. Pediatrics (1980) 1.12
[Is diagnosis of toxoplasmosis within the scope of prenatal care meaningful?]. Geburtshilfe Frauenheilkd (1992) 1.12
Incidence of anti-Toxoplasma antibodies in women with high-risk pregnancy and habitual abortions. Rev Soc Bras Med Trop (1996) 1.12
Decreased seroprevalence for Toxoplasma gondii in Seventh Day Adventists in Maryland. Am J Trop Med Hyg (1999) 1.11
Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect (1998) 1.10
Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol (1998) 1.10
Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J (2000) 1.09
Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis Suppl (1992) 1.09
Sources and reservoirs of Toxoplasma gondii infection on 47 swine farms in Illinois. J Parasitol (1995) 1.09
Economic losses caused by foodborne parasitic diseases. Parasitol Today (1994) 1.08
The prevalence and source of Toxoplasma infection in the environment. Adv Parasitol (1989) 1.07
Toxoplasmosis in an infant fed unpasteurized goat milk. J Pediatr (1975) 1.07
[Screening for toxoplasmosis in pregnancy--a pilot program in Northeast Germany]. Geburtshilfe Frauenheilkd (1993) 1.07
Changes in the personality profile of young women with latent toxoplasmosis. Folia Parasitol (Praha) (1999) 1.07
Acquired toxoplasmosis. Ophthalmology (1982) 1.06
Keratin expression in human tissues and neoplasms. Histopathology (2002) 4.91
Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol (1991) 4.48
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol (2000) 4.46
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol (1997) 3.83
Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol (1992) 3.33
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med (1995) 3.31
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol (1984) 2.53
Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol (1991) 2.37
Chagas' disease. Clin Microbiol Rev (1992) 2.30
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med (1993) 2.27
Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol (1994) 2.23
Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol (1995) 2.22
SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma. Blood (1989) 2.17
Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol (1987) 2.10
Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol (1997) 2.09
New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am J Clin Pathol (1992) 2.02
Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med (1988) 1.99
The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol (1995) 1.92
Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol (2001) 1.91
Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol (1991) 1.89
Detection of Epstein-Barr Virus in inflammatory pseudotumor. Semin Diagn Pathol (1998) 1.86
Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood (1993) 1.82
Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol (1992) 1.75
Small subunit rRNA sequence of Enterocytozoon bieneusi and its potential diagnostic role with use of the polymerase chain reaction. J Infect Dis (1993) 1.73
Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol (1993) 1.71
Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med (1985) 1.68
Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun (2001) 1.66
Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors. Am J Surg Pathol (1997) 1.62
Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol (1992) 1.60
Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol (1992) 1.58
Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature. Am J Surg Pathol (1998) 1.56
Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med (1986) 1.53
Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol (1998) 1.50
Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol (1999) 1.49
Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol (1986) 1.43
Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol (1985) 1.43
Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Arch Pathol Lab Med (1997) 1.40
The effect of decalcification on in situ hybridization. Mod Pathol (1997) 1.39
Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect Immun (1998) 1.37
c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol (1994) 1.34
Prevalence of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon (Septata) intestinalis among patients with AIDS-related diarrhea: determination by polymerase chain reaction to the microsporidian small-subunit rRNA gene. Clin Infect Dis (1996) 1.33
Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol (1986) 1.32
Initial characterization of CST1, a Toxoplasma gondii cyst wall glycoprotein. Infect Immun (2001) 1.31
Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology (2004) 1.29
Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol (2001) 1.28
The gamma interferon (IFN-gamma)-inducible GTP-binding protein IGTP is necessary for toxoplasma vacuolar disruption and induces parasite egression in IFN-gamma-stimulated astrocytes. Infect Immun (2008) 1.26
Serological evidence of human infection with the protozoan Neospora caninum. Clin Diagn Lab Immunol (1999) 1.25
Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion. Hum Pathol (1997) 1.23
Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol (1992) 1.21
Cloning of a bradyzoite-specific gene of Toxoplasma gondii encoding a cytoplasmic antigen. Mol Biochem Parasitol (1995) 1.21
Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun (1999) 1.21
An immunohistochemical method for detecting bradyzoite antigen (BAG5) in Toxoplasma gondii-infected tissues cross-reacts with a Neospora caninum bradyzoite antigen. J Parasitol (1996) 1.19
Disseminated Aspergillus ustus infection following cardiac surgery. Am J Clin Pathol (1983) 1.19
Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. Hum Pathol (1992) 1.19
Identification of a microsporidian polar tube protein reactive monoclonal antibody. J Eukaryot Microbiol (1996) 1.18
Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation. Mol Microbiol (1999) 1.18
Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med (1988) 1.17
Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer (1990) 1.16
The molecular characterization of the major polar tube protein gene from Encephalitozoon hellem, a microsporidian parasite of humans. Mol Biochem Parasitol (1998) 1.16
Nucleotide sequence of the small ribosomal RNA of Encephalitozoon cuniculi. Nucleic Acids Res (1993) 1.16
The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol (2001) 1.15
Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch Otolaryngol Head Neck Surg (1995) 1.15
No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol (2001) 1.14
CT demonstration of an esophageal duplication cyst. J Comput Assist Tomogr (1983) 1.14
Non-Hodgkin's lymphoma involving the breast. Am J Surg Pathol (1994) 1.13
Identification of Toxoplasma gondii bradyzoite-specific monoclonal antibodies. J Infect Dis (1992) 1.13
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA (1999) 1.11
Large solitary fibrous tumor of the kidney: report of two cases and review of the literature. Am J Surg Pathol (2001) 1.11
Investigation into the mechanism of gamma interferon-mediated inhibition of Toxoplasma gondii in murine astrocytes. Infect Immun (2000) 1.10
Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol (1998) 1.10
TNP-470 is an effective antimicrosporidial agent. J Infect Dis (1998) 1.09
Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol (1996) 1.09
Compromised microcirculation in acute murine Trypanosoma cruzi infection. J Parasitol (1996) 1.09
Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study. J Neuroparasitology (2010) 1.08
Gastrointestinal lymphomas. Immunohistochemical studies on the cell of origin. Am J Surg Pathol (1985) 1.08
Microsporidiosis in South Africa: PCR detection in stool samples of HIV-positive and HIV-negative individuals and school children in Vhembe district, Limpopo Province. Trans R Soc Trop Med Hyg (2007) 1.08
Non-Hodgkin's lymphoma containing both B and T cell clones. Blood (1987) 1.08
Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest (1987) 1.07
Lobular capillary hemangioma. An immunohistochemical study including steroid hormone receptor status. Am J Clin Pathol (1992) 1.07
Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic" neoplasms. Am J Pathol (1985) 1.07
Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease). Am J Pathol (1987) 1.07
High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood (1993) 1.06
Treatment of lymphoblastic lymphoma in adults. J Clin Oncol (1986) 1.06
Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol (1996) 1.06
Brachiola vesicularum, n. g., n. sp., a new microsporidium associated with AIDS and myositis. J Eukaryot Microbiol (1998) 1.05
Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. Am J Surg Pathol (1999) 1.05
Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol (2000) 1.05
Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. Cancer (1988) 1.04
Immune response to Encephalitozoon cuniculi infection. Microbes Infect (2001) 1.03
Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. Am J Pathol (1988) 1.03
Parasitic infections in AIDS patients. Cryptosporidiosis, isosporiasis, microsporidiosis, cyclosporiasis. Infect Dis Clin North Am (1993) 1.03
Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol (1996) 1.03
The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am J Pathol (1991) 1.02
Primary plasmacytoma of lymph nodes. Hum Pathol (1997) 1.02
Characterization and function of the microsporidian polar tube: a review. Folia Parasitol (Praha) (1998) 1.02
The immunology of parasite infections in immunocompromised hosts. Parasite Immunol (2006) 1.01
Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease. Leukemia (1992) 1.01